HR 5233

Extend Act

In Committee

Jurisdiction

US Congress

Session

Session 116

Last updated at

Jun 13, 2026, 5:10 PM

Official source

Take action

Introduced
Passed House
Passed Senate
To President
Became Law

Bill overview

This bill, the Extend Act, seeks to keep a temporary federal order in place that classifies many fentanyl-related substances as Schedule I drugs. Currently, this order, issued by the Drug Enforcement Administration, is set to expire on February 6, 2020. By extending this order, the bill aims to maintain the existing restrictions on these substances. This extension would provide continued federal control over the handling and distribution of these drugs.

Sponsors

Official sponsors from legislative records.

Primary sponsor

Brian K. Fitzpatrick

HousePARepublicanDistrict 1

Cosponsors

Ann M. Kuster

HouseNHDemocratDistrict 2

Anthony Brindisi

HouseNYDemocratDistrict 22

Brian J. Mast

HouseFLRepublicanDistrict 18

Gilbert Ray, Jr. Cisneros

HouseCADemocratDistrict 39

Positions across the state

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Chronological record of actions on this bill from official records.

2019-12-19House

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Read the latest version inline or switch to a previous version.

HR 5233

Take action

Bill overview

Sponsors

Primary sponsor

Cosponsors

Positions across the state

Arguments in favor

Arguments opposed

Legislative history

Bill text

Positions across the state

Legislative history